Characterization of the Early Humoral and Cellular Response Developed in Oncohematological Patients Post-Vaccination with One Dose Against COVID-19

Background: Oncohematological patients present a variable immune response against many vaccines, due to the immunodeficiency caused by the disease and its treatment. The experience of vaccination against COVID-19 in oncohematological patients is low and mostly limited to studies of humoral immunity....

Descripción completa

Detalles Bibliográficos
Autores principales: Corona De Lapuerta, Magdalena, Rodriguez-Mora, Sara, Casado-Fernandez, Guiomar, Garcia-Pérez, Javier, Vigon, Lorena, Murciano-Antón, María Aranzazú, Blanchard, María Jesús, Marquet Palomanes, Juan, Martin Moro, Fernando, Palomo Rumschisky, Pablo, Pérez-Olmeida, Mayte, López Jiménez, Javier, López-Huertas, Maria Rosa, Coiras, Maria Teresa, Garcia Gutierrez, Valentín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
203.Lymphocytes and Acquired or Congenital Immunodeficiency Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701633/
http://dx.doi.org/10.1182/blood-2021-152943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701633/
http://dx.doi.org/10.1182/blood-2021-152943

Ejemplares similares